Correction
Executive Summary
During a recent formulary management conference, PCS VP-Network Administration Douglas Stephens referred to a switch program for Miles Adalat CC as an example of pharmacists being paid to switch to manufacturers' products. Mylan was not involved in the program discussed by Stephens (1"The Pink Sheet" Aug. 9, p. 11)